Thomas J. Schall - 11 Mar 2024 Form 3 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Thomas J. Schall
Issuer symbol
IMRX
Transactions as of
11 Mar 2024
Net transactions value
$0
Form type
3
Filing time
12 Mar 2024, 08:31:39 UTC
Previous filing
24 Oct 2022
Next filing
25 Mar 2024

No securities are beneficially owned.